MPI 42511
Latest Information Update: 10 Aug 2007
At a glance
- Originator Myriad Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 10 Aug 2007 Discontinued - Preclinical for Colorectal cancer in USA (unspecified route)
- 19 Apr 2006 This compound is still in active development
- 28 Sep 2001 This compound is still in active development